J Korean Ophthalmol Soc > Volume 50(11); 2009 > Article
Journal of the Korean Ophthalmological Society 2009;50(11):1717-1723.
DOI: https://doi.org/10.3341/jkos.2009.50.11.1717    Published online November 15, 2009.
Clinical Observations on Tolosa-Hunt Syndrome.
Han Kee Lee, Sul Gee Lee
1Department of Ophthalmology, College of Medicine, Inje University, Busan, Korea. judysg@hanmail.net
2Department of Ophthalmology, Research Foundation, Inje University, Busan, Korea.
톨로사 헌트 증후군에 대한 임상적 고찰
이한기ㆍ이슬기
Department of Ophthalmology, College of Medicine, Inje University, Busan, Korea, Department of Ophthalmology, Research Foundation, Inje University, Busan, Korea
Abstract
PURPOSE
The authors reviewed clinical features, response to treatment and recurrence rate of Tolosa-Hunt syndrome. METHODS: A retrospective chart review was performed on 6 patients, who fulfilled the diagnosis for Tolosa-Hunt syndrome according to the International Headache Society (IHS) classification of 2004. RESULTS: Every patient had orbital pain as a first symptom, followed by cranial nerve paresis. The third cranial nerve was most commonly involved (83.3%), followed by the sixth nerve (50%), the forth nerve (16.7%), and the first branch of the fifth cranial nerve (16.7%). Two of the patients showed multiple cranial nerve paresis (33.3%, 2 out of 6). All patients received high-dose steroid therapy for more than 5 days, and all patients had resolution of orbital pain within 72 hours of treatment. Full recovery of cranial nerve paresis occurred on average in 2.3 months (3 days to 12 months). During the 29 months of follow-up, 2 patients (33.3%) had a recurrence episode. CONCLUSIONS: Tolosa-Hunt syndrome responds well to steroid therapy, and full recovery is possible with proper treatment. The exact diagnosis and treatment of Tolosa-Hunt syndrome is important. Because Tolosa-Hunt syndrome often recurs after full recovery, the authors suggest a minimum follow-up period of 2 years.
Key Words: Painful ophthalmoplegia;Tolosa-Hunt syndrome


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next